Registre pour les patients pédiatriques traités par radiothérapie : collecte de données et suivi à long terme
Cette étude vise à créer un registre pour les patients pédiatriques traités par thérapie de radiation par protons aux États-Unis, avec un accent sur la collecte de données et le suivi à long terme.
Collecte de données
Données recueillies dès le début de l'étude - ProspectiveCohorte
Suivi d'un groupe de personnes dans le temps pour mieux comprendre les causes et l'évolution d'une maladie.Résumé
Date de début de l'étude : 1 juillet 2012
Date à laquelle le premier participant a commencé l'étude.Once you are enrolled in the study, you will receive treatment, evaluations and follow up care for your type of cancer as determined by your treating physician according to clinical judgment and standard of care for your clinic. All treatments that you receive will be recorded, including all surgeries and chemotherapy given before or after PBRT. Treatment outcomes, like how you respond to treatment, side effects, and progression of your cancer will be collected as the information becomes available. A study coordinator or research nurse at your clinic will perform a chart review annually to update your status in the database. The study doctor will request any new data within the past year from you or your doctor. We will be collecting the following data for the Registry: At Screening: The following data will be collected from the time of diagnosis and initial staging: * Patient demographics, date of birth, gender, race, zip code and insurance status * Date of diagnosis * Histologic or clinical diagnosis and staging relevant to diagnosis * Imaging studies obtained and tumor measurements * Lab evaluations which include routine blood tests, hormone levels, and any relevant lab results needed to assess you and baseline and follow-up visits * Referring physician contact information Treatment Data Collection: The following data regarding treatment will be collected: * Treatments received before radiation therapy, including surgery, chemotherapy, dates and numbers of cycles, results of chemotherapy if available * Dates and doses of radiation treatment * Side effects observed * Any treatments you received at the same time as proton radiation therapy Follow-up Data Collection: The following data will be collected either as it comes in or annually following completion of your radiation therapy treatment: * Disease and survival status * Hospitalization, surgeries or other procedures * New diagnoses of medical conditions * Any lab results, including x-rays * Medications you are taking * Late side effects such as hearing loss, hormonal issues, any cardiac issues * Development of any new types of cancers * Dates of treatment after radiation therapy * If you discontinued radiation therapy * Laboratory/physician/dental or psychological evaluations * Use of special services in school (IEP, FM hearing system, one on one tutor, special education) We would like to keep track of your medical condition for the rest of your life. We would like to do this by contacting you or your doctor once a year to see how you are doing. Keeping in touch with you and checking on your condition helps determine the long-term outcomes of individuals treated with proton beam radiation therapy. In addition to research personnel at MGH, there are others that may have access to the data collected. This includes: * Other research doctors and medical centers participating in this research, if applicable * Outside individuals or entities that have a need to access this information to perform functions relating to the conduct of this research. For instance copies of your imaging studies and treatment plan will be stored at MIMcloud. MIMcloud is a service offered through MIM Software Inc, a privately held company, that provides diagnostic imaging data management services.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.5000 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Cohorte
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.Jusqu'à 21 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Critères
Eligibility Criteria: 1. Patients treated with radiation therapy at one of the participating centers 2. Age \< 22 at time of treatment start. 3. Patients may be enrolled regardless of previous local or systemic treatments received prior to enrollment in the PPCR. 4. Patients may be enrolled regardless of other current local or systemic treatments or disease extent. 5. Patients may be enrolled on the PPCR concurrently with another study or clinical trial.
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.Un seul groupe d'intervention est désigné dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Objectifs de l'étude
Objectifs principaux
Objectifs secondaires
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 26 sites
California Protons Cancer Therapy Center
San Diego, United StatesUniversity of California San Francisco
San Francisco, United StatesUniversity of Florida Health Proton Therapy Institute
Jacksonville, United States